COPD is a group of progressive lung diseases that includes emphysema and chronic bronchitis. Despite affecting an estimated 32 million people in the United States, as many as half are unaware they ...

Mepolizumab, a humanized monoclonal antibody that targets interleukin-5 (IL-5), significantly reduced COPD exacerbations in ...

The COPD approval marks the fifth Nucala has received from the FDA, following green lights in severe asthma, chronic ...

When you are diagnosed with COPD, it is important to remember that you are not alone. A healthcare team, which may include a ...

Australia’s new asthma guidelines warn against anyone with asthma – even those with infrequent symptoms – using only ...

Chronic obstructive pulmonary disease (COPD) affects millions of Americans, with new data from the National Center for Health Statistics showing the condition becomes increasingly common as people age ...

Current recommendations for diagnosis of COPD in patients with respiratory symptoms require detection of airflow obstruction ...

Inhalers have been key to asthma management since the 1950s. The most common, salbutamol, comes in a familiar blue-colored inhaler (or "puffer").

My cat coughing up phlegm: understand the underlying causes and learn evidence-based treatment methods to ensure your cat's well-being.

Cheap, durable, and low maintenance — synthetic fibres offer the kind of convenience modern life thrives on. However, beneath ...

Children and adolescents with asthma are especially vulnerable. Exposure to e-cigarette aerosols can trigger asthma attacks, reduce medication effectiveness, impair lung function, and slow lung ...

GSK’s Nucala receives US FDA approval for use in adults with chronic obstructive pulmonary disease: London, UK Saturday, May 24, 2025, 11:00 Hrs [IST] GSK plc announced that the ...